3D-Printed Models Improve Precision in Cancer Surgery

Personalized visualization guides complex head and neck cancer removals

Translate to Spanish or other 102 languages!

Using custom 3D-printed models to plan head and neck cancer surgeries increased precision, achieving complete tumor removal in 92% of cases with bone invasion in a recent study published by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). Image for illustration purposes
Using custom 3D-printed models to plan head and neck cancer surgeries increased precision, achieving complete tumor removal in 92% of cases with bone invasion in a recent study published by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). Image for illustration purposes
- Advertisement -

By Ohio State University Wexner Medical Center 

Newswise – COLUMBUS, Ohio – Using custom 3D-printed models to plan head and neck cancer surgeries increased precision, achieving complete tumor removal in 92% of cases with bone invasion in a recent study published by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

“The precision of what we take out is critical to ensure we get the whole tumor, but not so much that we’re devastating the patient’s function in the long term and taking out things that don’t need to be removed,” said Kyle VanKoevering, MD, an otolaryngologist (head and neck surgeon) at the OSUCCC – James and medical director of the M4 Lab (Medical Modeling, Materials and Manufacturing Lab) within the Ohio State College of Engineering. “This 3D modeling being completely personalized to each patient is really helping improve the precision in the operating room.”

- Advertisement -
Key takeaways
3D-printed models tailored to each patient improve tumor removal accuracy in head and neck cancers.
In surgeries using 3D models, 92% achieved complete tumor removal vs 74% without models.
Greater precision protects healthy tissue, potentially reducing need for additional treatments.

3D-guided surgery versus regular surgery
For this research, VanKoevering and team compared the surgical outcomes of 68 patients with bone-invading head and neck cancers treated at the OSUCCC – James. Thirty-seven patients received in-house 3D models for intraoperative use while the other 31 did not. The study population was predominantly male, and nearly all were active or previous tobacco users (94.6%).                                                                                                                                                                                     

Surgeries with access to a patient-specific 3D-model to use as a visual planning aid in the operating room had better negative surgical margins – meaning the surrounding tissue showed no evidence of cancer – compared with the group that did not have the assistance of a 3D model.

“This model is especially critical in cancers that have invaded bone, because tumor boundaries are often less visible or palpable. Our 3D models are built based on the patient’s actual tumor imaging, so it gives us a much better visual map at the patient’s bedside for removing the cancer as completely as possible while also sparing important structures and tissue to maintain function after surgery,” VanKoevering explained.

This study looked at the cancer-control impact of using custom, 3D-printed models of a patient’s anatomy to plan complex surgeries impacting the head and neck, where delicate structures that impact speech, chewing and swallowing are often impacted.

- Advertisement -

Matthew Marquardt, study corresponding author and third-year medical student, noted that this is the first study to evaluate the ability of 3D modeling to help improve cancer control in the operating room.

“This really sets the stage for larger studies looking at how 3D modeling can enhance surgery planning and precision, not just in the field of head and neck cancer surgery but in other areas that involve bone and soft tissue, like orthopedics,” said Marquardt, who worked on this project as part of a focused medical school research year through the Pelotonia Scholars Program.

“Long term, our hope is that this work will enable other surgeons to use this technology across the country to help improve people’s lives and improve cancer outcomes,” said Marquardt.

The team reports their findings in the September 2025 issue of the journal Oral Oncology. The Pelotonia-funded study was co-authored by Taylor Freeman, Amanda Pancake, Joseph Lee, MD, James Rocco, MD, PhD, Matthew Old, MD, Stephen Yang, MD, Lauren Miller, MD, Catherine Haring, MD, Nolan Seim, Enver Ozer, MD, Amit Agarwal, MD, Rachel Herster, Teri Snyder and Megan Malara.

To learn more about cancer care and research at the OSUCCC – James, visit cancer.osu.edu or call 1-800-293-5066.

About the Pelotonia Scholars Program

Since 2010, the Pelotonia Scholars program has funded more than 500 multidisciplinary cancer research projects led by undergraduate, graduate, medical and postdoctoral students at The Ohio State University. These projects are conducted in partnership with faculty mentors in OSUCCC – James research labs. To learn more about Pelotonia and ways to get involved in the organization’s mission to raise funds for live-saving research at the OSUCCC – James, visit pelotonia.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Why Strength Training Is Your Best Defense Against Osteoporosis

Reports show women are at higher risk for developing the bone weakening condition as they get older.

Social Security Administration Corrects Millions of Records in Major Database Cleanup

The Social Security Administration (SSA) announced on October 20, 2026, that it has corrected millions of Social Security number records in what the agency describes as its most comprehensive record-integrity initiative in 91 years.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

A UTHealth Houston Physician Turned a Texas Teen’s Frightening Diagnosis into a Champion Title

Two years ago, Geordon Boulware, now 15, was at a routine dental visit in his hometown of Lufkin, Texas, when his dentist discovered he had an abnormal growth on his jaw. After meeting with a local oral surgeon, Geordon and his mom decided to seek treatment in Houston. 
- Advertisement -